Highly-invasive surgeries have been the standard treatment for babies born with heart defects for decades. A newly FDA- approved stent designed to grow with the child offers a better option. Oct.
17, 2024.
Highly-invasive surgeries have been the standard treatment for babies born with heart defects for decades. A newly FDA- approved stent designed to grow with the child offers a better option.
Highly-invasive surgeries have been the standard treatment for babies born with heart defects for decades. A newly FDA- approved stent designed to grow with the child offers a better option. Oct.
17, 2024.